Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(75.0%)
Phase 2
1(25.0%)
4Total
Phase 1(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00652600Phase 1Completed

Bioavailability Study of Propranolol Under Fed Conditions

Role: collaborator

NCT00637403Phase 1Terminated

Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

Role: collaborator

NCT00638079Phase 1Completed

Evaluating the Effect of Food on Absorption of Megace ES

Role: collaborator

NCT00653120Phase 2Completed

Bioavailability Study of Propranolol Under Fasting Conditions

Role: collaborator

All 4 trials loaded